Selected article for: "control group and infected group"
Author: Laine, Outi; Joutsi-Korhonen, Lotta; Lassila, Riitta; Huhtala, Heini; Vaheri, Antti; Mäkelä, Satu; Mustonen, Jukka
Title: Elevated thrombopoietin and platelet indices confirm active thrombopoiesis but fail to predict clinical severity of puumala hantavirus infection
  • Document date: 2016_12_30
    • ID: jhcc6eex_22
    Snippet: D-dimer was 7-fold higher acutely compared with the value measured at control visit in this group of PUUV-infected patients. F1 + 2 was clearly elevated ( Table 2 ) and it associated with serum TPO level (r = 0.47, P = 0.03). Both D-dimer and F1 + 2 associated with minimum platelet count (r = À0.48, P = 0.01 and r = À0.46, P = 0.02, respectively), plasma creatinine level at the time of the measurement (r = 0.57, P = 0.002 and r = 0.50, P = 0.00.....
    Document: D-dimer was 7-fold higher acutely compared with the value measured at control visit in this group of PUUV-infected patients. F1 + 2 was clearly elevated ( Table 2 ) and it associated with serum TPO level (r = 0.47, P = 0.03). Both D-dimer and F1 + 2 associated with minimum platelet count (r = À0.48, P = 0.01 and r = À0.46, P = 0.02, respectively), plasma creatinine level at the time of the measurement (r = 0.57, P = 0.002 and r = 0.50, P = 0.008, respectively) and maximum plasma creatinine (r = 0.54, P = 0.004 and r = 0.42, P = 0.03, respectively). MPs' activity in the acute phase of the disease did not differ from the activity observed at the recovery when patients were divided into 2 groups (below or above median value) based on the platelet count at the time of the MPs' activity measurement or the lowest platelet count.

    Search related documents:
    Co phrase search for related documents
    • activity measurement and control visit: 1
    • activity measurement and disease acute phase: 1
    • activity measurement and measurement time: 1
    • activity measurement and serum TPO level: 1
    • activity measurement and TPO level: 1
    • acute phase and control visit: 1
    • acute phase and disease acute phase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74
    • acute phase and disease acute phase activity: 1, 2, 3
    • acute phase and low platelet count: 1
    • acute phase and maximum plasma creatinine: 1
    • acute phase and measurement time: 1, 2, 3, 4, 5
    • acute phase and median value: 1, 2, 3, 4, 5
    • acute phase and minimum platelet count: 1
    • acute phase and MPs disease acute phase activity: 1
    • acute phase and plasma creatinine: 1, 2
    • acute phase and plasma creatinine level: 1
    • acute phase and platelet count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute phase and recovery observe: 1
    • acute phase and serum TPO level: 1, 2, 3, 4, 5, 6